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Abstract 
Simulators, as tools that can clearly bring out the effect of 
impairment, are invaluable in the design and development 
process of an assistive device. Simulators are vital in meeting 
high standards of accessibility. Described is our work on a 
smartphone-based vision simulator for diabetic retinopathy 
that is economic, portable, flexible and easy-to-use.   
1 Introduction 
Accessibility is increasingly considered important in the 
design of any product. The current design flow for making the 
design accessible includes incorporating a list of good design 
practices or guidelines followed by verifying compliance with 
regulations (often using an automatic validator). 
 
The validators are rule checking systems. For example, 
evaluating the accessibility of a webpage involves checking if 
every graphic in a web page has an alternate text version. 
While these rules are targeted at the barriers that an individual 
with impairment may encounter, it is difficult for the designer 
to evaluate first-hand the effectiveness of any single 
accessibility feature. Nonetheless, being able to do that 
evaluation is important. Most of all, it gives the designer a 
level of confidence about the accessibility of the design and 
helps make an estimate of how much more to do. Secondly, 
there may be factors specific to the design that the guidelines 
do not cover. 
 
Therefore, there is a strong case for simulators or perhaps a 
whole suite of them that can also be easily incorporated into 
the design flow. Our work on a vision simulator for diabetic 
retinopathy is based on this philosophy.  
2 Vision simulator for diabetic retinopathy 
As part of the course, “Sensory, Motor and Language 
Disorders”, the first in a series on Assistive Technology 
offered as a minor at Indian Institute of Technology Madras, 
we designed a vision simulator for diabetic retinopathy. 
 
Diabetic retinopathy (DR) is a microvascular complication of 
diabetes mellitus which currently affects more that 170 
million persons worldwide and will affect an estimated 336 
million by 2030. DR develops in more than 75% of the 
patients who have had diabetes mellitus for more than 20 
years [1]. The current simulator is an Android Application 
that captures video from the phone’s camera and displays it 
on the screen just as a person with diabetic retinopathy is 
likely to see.  
 
2.1 Implementation details 
 
 
Figure 1: Vision Simulator 
 
The simulator was built as an Android application using 
OpenCV (an open source computer vision library) to do the 
image processing. The application is compatible currently 
with Android 3.0 and above.  
2.2 Simulations of stages of diabetic retinopathy 
For normal vision, only a small oasis of clarity exists at the 
point of fixation and the scene grows progressively blurred at 
the periphery. On the other hand, when the same scene is 
viewed through a camera, there is no difference between the 
clarity of the centre and periphery. Hence, to reasonably 
simulate normal vision on the screen we introduced eccentric 
blurring.  Values from prior studies [2] have been used to 
increasingly blur the image as we go away from the centre 
using a built-in blurring function of OpenCV. 
 
DR is often associated with other complications resulting 
from the effect of diabetes on all retinal cell types [3]. We 
have included a few of the associated complications as well in 
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the simulator. The progressive vision loss has been divided 
into four stages which approximately follow the 
ophthalmological classification. 
 
The initial stage of DR is termed as non-proliferative (NPDR) 
and causes no vision loss. However, macular edema, an 
associated complication, is known to be a major cause of 
visual deterioration in patients with DR [4].  Macular edema 
causes loss of central vision simulated as a hazy spot in the 
centre of the scene. This has implications on the quality of 
communication and mobility (Figure 2). Using the simulator, 
some of the problems we identified included difficulty in 
making out facial expressions of an individual, identifying 
objects or people in crowded situations, detecting curbs and 
correctly recognising road signs and traffic signals. 
 
  
 
Figure 2: (A) Original scene (B) Screenshot of the simulator 
showing degeneration of central vision affecting reading. Notice 
the blurred "legend". 
  
Studies have shown that patients with DR have an increased 
incidence of acquiring tritanopia (blue-yellow colour 
blindness) [5]. Moreover, the treatment of DR with laser 
photocoagulation is shown to produce permanent tritanopia 
[6]. Using simulation matrices [7], in stage 2 we have 
simulated blue-yellow colour deficit with different severities.  
The major implication of this acquired deficit will be in home 
glucose monitoring which depends on correctly interpreting 
the blues and yellows in colour-reagent test strips and may 
involve comparing the strip colour to a colour concentration 
chart (Figure 3). 
 
  
 
Figure 3: (A) Original scene (B) Screenshot of the simulator 
showing blue-yellow colour deficiency. Notice that the sharpener 
and the pen appear to have the same colour. 
  
In NPDR, the blood vessels in the retina are weakened and 
tiny bulges called microaneurysms protrude from their walls. 
To improve blood circulation in the retina, new fragile blood 
vessels may form on the retinal surface which can leak blood 
into the vitreous. Patients may see a few specks of blood in 
their field of vision and some clouding which tends to 
disappear gradually. These effects are simulated in stage 3. 
The next stage of DR – proliferative diabetic retinopathy 
(PDR) is associated with severe vision loss and black patches 
that appear in the field of vision (Figure 4). 
 
 
   
 
Figure 4: (A) Original scene (B) Screenshot of the simulator 
showing a row of switches. With reduced contrast sensitivity and 
acuity along with the black patches, it is difficult to make out 
which switch is on from a distance.   
3 Discussion 
Using a mobile application on smartphone has a big 
advantage in terms of portability. The simulator can be used 
on the spot to see how vision loss affects communication, 
learning and mobility. For a designer, this is important in 
ensuring the completeness of the design. As described earlier 
bringing in accessibility is often about fulfilling a checklist of 
good practices. However, these generic recommendations do 
not cover all situations and in many cases there may be issues 
specific to the problem at hand. An example of this will be 
the home glucose monitoring mentioned earlier. Such 
considerations are often easily overlooked and this is where 
the rule based approach becomes cumbersome. Instead, if the 
measuring process is rehearsed with the simulator in place, 
there are high chances that the difficulties will become 
apparent. 
 
We can never be sure if a simulator correctly reproduces the 
actual vision loss. The process of development will invariably 
involve a lot of trial and error. The ease with which the code 
can be changed is an advantage over hardware simulators. 
 
Development of an assistive device involves asking a patient 
to use a prototype repeatedly and give feedback. This is not 
only time-consuming, but may also turn out to be frustrating 
for both the designer and patient. To make the product more 
generic and cater to a wider section of people would also need 
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such trials to be repeated on many patients. When products 
are designed by able-bodied individuals who may not fully 
understand the limitations or strengths of the user’s disability, 
a simulator provides an inexpensive and versatile method of 
recognising it in the preliminary stages. Parameters can be 
modified to reasonably model different scenarios. Further, 
simulators can model future scenarios which would be 
especially useful in designing products for degenerative 
disorders.  
 
Our vision simulator is quite effective in showing the effect of 
visual deterioration due to DR on communication, learning 
and mobility. However, each stage is only an average case in 
the progression of DR and may not exactly match an 
individual’s experience. Also, there might be situations where 
discrete steps are not sufficient to evaluate a design’s 
effectiveness. We have observed that the image processing 
for eccentric blurring causes a delay which makes the 
simulation sluggish. Being able to calibrate the simulation 
with an individual patient’s medical record which has details 
of his/her acuity, contrast sensitivity, colour vision, retinal 
scans etc. will be a useful, albeit challenging addition to the 
simulator. 
4 Conclusion 
The key challenge in the development of products for people 
with disabilities as well as in making existing designs 
accessible is the lack of understanding of the disability itself. 
With the help of a portable simulator, designers can put 
themselves in the shoes of the user. Further, the simulator’s 
flexibility makes it easy to evaluate the design’s effectiveness 
over a range of disabilities and its varying degrees.  
Thus, wide adoption of simulators will go a long way in 
setting high standards of accessibility. It will also make for a 
common benchmark against which new designs can be 
compared. 
Simulators on smartphones can serve well not only to help the 
designer but also aid the person with disability or the 
caregiver to make suitable lifestyle changes to enable 
independent living. 
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